OncoSec Medical Incorporated

OTCPK:ONCS.Q Stock Report

Market Cap: US$805.0k

OncoSec Medical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure9.7yrs

Recent management updates

Recent updates

OncoSec to cut workforce by 45% as part of corporate restructuring

Oct 04

What Type Of Shareholders Make Up OncoSec Medical Incorporated's (NASDAQ:ONCS) Share Registry?

Jan 28
What Type Of Shareholders Make Up OncoSec Medical Incorporated's (NASDAQ:ONCS) Share Registry?

Dosing underway in OncoSec's Tavo combo trial in skin cancer

Jan 08

OncoSec: Undervalued And Continuing To Make Progress

Nov 18

OncoSec drops 11% despite positive data from TAVO + Merck's Keytruda in metastatic melanoma

Nov 09

CEO

OncoSec Medical has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Richard Heller
Member of Scientific Advisory Board12.4yrsno datano data
Walter John Urba
Member of Clinical Advisory Boardno datano datano data
Iacob Mathiesen
Member of Scientific Advisory Board12.4yrsno datano data
Pamela Munster
Member of Clinical Advisory Boardno datano datano data
Axel Hauschild
Member of Clinical Advisory Board10.3yrsno datano data
Soldano Ferrone
Member of Scientific Advisory Board9yrsno datano data
Alain Algazi
Member of Clinical Advisory Board4.8yrsno datano data
Julie Shin
Board Observer4.5yrsno datano data
Robert H.I. Andtbacka
Member of Clinical Advisory Boardno datano datano data
Georgina Long
Member of Clinical Advisory Boardno datano datano data

9.7yrs

Average Tenure

Experienced Board: ONCS.Q's board of directors are considered experienced (9.7 years average tenure).